全文获取类型
收费全文 | 1799篇 |
免费 | 247篇 |
国内免费 | 269篇 |
专业分类
化学 | 1601篇 |
晶体学 | 2篇 |
力学 | 33篇 |
综合类 | 34篇 |
数学 | 90篇 |
物理学 | 555篇 |
出版年
2024年 | 1篇 |
2023年 | 63篇 |
2022年 | 84篇 |
2021年 | 248篇 |
2020年 | 228篇 |
2019年 | 103篇 |
2018年 | 107篇 |
2017年 | 100篇 |
2016年 | 96篇 |
2015年 | 99篇 |
2014年 | 119篇 |
2013年 | 141篇 |
2012年 | 93篇 |
2011年 | 102篇 |
2010年 | 70篇 |
2009年 | 68篇 |
2008年 | 79篇 |
2007年 | 67篇 |
2006年 | 68篇 |
2005年 | 67篇 |
2004年 | 60篇 |
2003年 | 50篇 |
2002年 | 27篇 |
2001年 | 30篇 |
2000年 | 27篇 |
1999年 | 23篇 |
1998年 | 17篇 |
1997年 | 18篇 |
1996年 | 8篇 |
1995年 | 5篇 |
1994年 | 3篇 |
1993年 | 8篇 |
1992年 | 5篇 |
1991年 | 6篇 |
1990年 | 9篇 |
1989年 | 1篇 |
1988年 | 2篇 |
1987年 | 1篇 |
1986年 | 4篇 |
1985年 | 3篇 |
1984年 | 2篇 |
1982年 | 2篇 |
1971年 | 1篇 |
排序方式: 共有2315条查询结果,搜索用时 218 毫秒
11.
12.
Ginette Ratovo Jean‐Pierre Souchard Pascale Urizzi Yvon Coulais Franoise Nepveu Etienne Hollande 《应用有机金属化学》2004,18(1):1-8
Pancreatic cancer has an extremely poor prognosis, due, in part, to lack of methods for early diagnosis. The present study was designed to evaluate the potential of labeling low‐density lipoprotein (LDL) with a radionuclide using a lipid chelating agent, bis(stearylamide) of diethylenetriaminepentaacetic acid (L), to detect pancreatic tumors by gamma‐scintigraphy. Previous studies indicated that the difficulty of visualization of pancreatic tumors was due to their poor vascularization. This study compares the ability of two radiotracers, 111In–L–LDL and 153Gd–L–LDL to target highly vascularized rat pancreatic tumors (AR4‐2J) implanted in nude mice. Biodistribution studies showed that the tumor uptake of 111In–L–LDL and 153Gd–L–LDL tracers was twofold and fivefold higher respectively than with the controls (111In citrate and 153Gd citrate respectively). These tracers would thus be suitable for scintigraphic imaging. We show here that LDL could be employed as a delivery system for tracers such as 111In or 153Gd when these two radionuclides are complexed by a lipid‐chelating anchor, and that 111In–L–LDL and 153Gd–L–LDL enabled better visualization of the pancreatic tumor tissues, with a better result with 153Gd–L–LDL. Copyright © 2004 John Wiley & Sons, Ltd. 相似文献
13.
采用MTT比色法对体外培养的肿瘤细胞进行细胞毒作用实验,验证槲寄生蛋白注射液体外抗肿瘤效果.并且鉴定这种检测方法的有效性。实验结果表明槲寄生蛋白注射液有一定的体外抗肿瘤效果;MTT比色法是一种可用的体外细胞毒作用检测法,为新药品的开发提供了实验依据。 相似文献
14.
Reinhardt J. Heuer 《Journal of voice》1992,6(4):352-354
This paper presents a general schema for classifying treatment approaches for both functional and organic voice disorders. It's use is illustrated by a review of treatments for Spasmodic Dysphonia. Most behavioral approaches have been found to be unsuccessful except for mild cases. Inhalation speech as a compensatory technique has been reported as somewhat successful for those mild/moderate cases for whom medical/surgical treatment has not been available. The fact that organic treatment levels have been more successful in the treatment of Spasmodic Dysphonia may lend support to an organic etiology 相似文献
15.
16.
BNCT优化网格设计及相关算法研究 总被引:2,自引:0,他引:2
用MCNP蒙特卡罗程序模拟了硼中子俘获治疗(BNCT)3种国际基准网格模型, 并与
修正的Snyder椭球模型进行了比较. 在此基础上, 给出了一种保质量守恒、内存量少、易于产生输入文件的4种基本材料成分的BNCT网格模型. 计算结果表明, 在4mm网格下, 新模型可以达到基准模型的精度; 根据解析模型剂量随深度的变化规律, 研究构造了多网格组合模型, 在重要区域计算精度不损失的条件下, 计算时间大大缩短. 最后研究给出了一个既保证精度、又在可接受的时间内完成剂量计算的模型、样本数和相应的算法, 它基本上满足临床BNCT的要求. 相似文献
17.
红紫素-18酰亚胺衍生物的合成及其可见光谱的研究 总被引:2,自引:5,他引:2
选择脱镁叶绿酸 a甲酯为原料进行 3 位化学修饰和E环改造 .经 3 乙烯基的溴化氢加成和与联苯酚的亲核取代反应 ,完成了 3 位联苯氧基的引入 ;在碱性条件下 ,通过空气氧化将E环转变为环己二羧酸酐形成红紫素 18甲酯衍生物 ;所得氧化产物进而和盐酸羟胺反应 ,经胺解开环和再缩合成环构成N 羟基红紫素 18酰亚胺衍生物 ;对其羟基进行烷基化和酰基化 ,合成出N 取代红紫素 18酰亚胺衍生物 .同时讨论了化学结构变化对分子可见光谱的影响 .所合成新化合物的结构均经UV ,IR ,1 HNMR光谱和元素分析予以确认 相似文献
18.
Chemodynamic therapy(CDT) is an emerging endogenous stimulation activated tumor treatment approach that exploiting iron-containing nanomedicine as catalyst to convert hydrogen peroxide(H_2O_2)into toxic hydroxyl radical(·OH) through Fenton reaction.Due to the unique characteristics(weak acidity and the high H_2O_2 level) of the tumor microenvironment,CDT has advantages of high selectivity and low side effect.However,as an important substrate of Fenton reaction,the endogenous H_2O_2 in tumor is still insufficient,which may be an important factor limiting the efficacy of CDT.In order to optimize CDT,various H_2O_2-generating nanomedicines that can promote the production of H_2O_2 in tumor have been designed and developed for enhanced CDT.In this review,we summarize recently developed nanomedicines based on catalytic enzymes,nanozymes,drugs,metal peroxides and bacteria.Finally,the challenges and possible development directions for further enhancing CDT are prospected. 相似文献
19.
Fan Caiyun Jia Hongmei Deuther-Conrad Winnie Brust Peter Steinbach J?rg Liu Boli 《中国科学B辑(英文版)》2006,49(2):169-176
A novel 99mTc labeled complex, [N-[2-((2-oxo-2-(4-(3-phenylpropyl)piperazin-1-yl)ethyl) (2-mercaptoethyl)amino)acetyl]-2-aminoethanethiolato]Technetium(V)
oxide (PPPE-MAMA’-99mTcO) ([
99m
Tc]-2) has been designed and prepared based on the integrated approach. The corresponding rhenium complex (PPPE-MAMA’-ReO)(Re-2) has been prepared and characterized. In vitro competition binding assays show moderate affinity of Re-2 towards σ1 and σ2 receptors with K
i values of 8.67 ± 0.07 and 5.71 ± 1.88 μmol, respectively. Planar images obtained at 0.5 h, 4 h, 20 h after i.v. injection
indicate the accumulation of [
99m
Tc]-2 in MCF-7 human breast tumor bearing mice at 20 h. Furthermore, the accumulation of [
99m
Tc]-2 has been inhibited at 20 h after co-injection of [
99m
Tc]-2 plus haloperidol (1 mg/kg). Biodistribution studies of [
99m
Tc]-2 display an in vivo tumor uptake of 0.14% ± 0.01% ID/g at 24 h post i.v. injection with a tumor/muscle ratio of 6.02 ± 0.87. The above results
suggest that [
99m
Tc]-2, derived from a previously published lead compound, retains certain tumor uptake and affinity for σ receptors. [
99m
Tc]-2 may be used as a basis for further structural modifications to develop tumor imaging agents with high affinity for σ receptors. 相似文献
20.
吉西他滨是临床一线治疗恶性肿瘤的药物,但其4-位氨基(N4)易与脱氧胞苷脱氨酶(CDA)作用而失活,导致代谢稳定性差,严重影响了临床治疗效果。以吉西他滨为起始原料,经3步反应合成了N4保护的脂溶性吉西他滨衍生物(3a和3b),其结构经1H NMR,13C NMR和HR-MS(ESI)表征。体外活性测试结果显示:化合物3a对多种肿瘤细胞的抗增殖作用均强于临床药物吉西他滨(P<0.05)。酶稳定性实验结果表明:3a几乎不受CDA影响,代谢稳定性显著高于原药吉西他滨。 相似文献